Literature DB >> 17084575

Stability of artesunate in pharmaceutical solvents.

Karen Gaudin1, Marie-Hélène Langlois, Anne Barbaud, Chantal Boyer, Pascal Millet, Fawaz Fawaz, Jean-Pierre Dubost.   

Abstract

Stability of artesunate (ART) was established in three pharmaceutical solvents. The chromatographic conditions developed for this study were acetonitrile:potassium phosphate buffer 10 mM (40:60, v:v; pH 2.9) at 0.7 mL min(-1) with UV detection at 220 nm using a short X-Terra RP C18 column (50 mm x 3 mm, 3.5 microm). This isocratic condition led to the separation between ART and its main degradation products (i.e. alpha-DHA and beta-DHA) with analysis time of less than 4 min. The retention factors are 1.49, 2.26 and 2.79 min for alpha-DHA, beta-DHA and ART, respectively. This method was proved linear (r(2)=0.9995), accurate (R.S.D.=0.20), precise (R.S.D.=0.74) and robust. The system performance remained unaffected by pH variation from 2.6 to 3.2 and variation of acetonitrile percentage from 38 to 42. Stability of ART was assessed in ethanol, propylene glycol (PG) and polyethylene glycol 400 (PEG 400). Unfortunately none of these solvents prevented ART from degradation longer than 3 months. In ethanol, significant degradation of ART occurred after 3 months at room temperature and this degradation was characterised by numerous degradation products. In PEG 400, significant degradation was observed after only 1 month, however DHA was the unique degradation product, which is also an efficient anti-malarial drug.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17084575     DOI: 10.1016/j.jpba.2006.09.039

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  1 in total

1.  Capillary electrophoresis for the assay of fixed-dose combination tablets of artesunate and amodiaquine.

Authors:  N'Cho Christophe Amin; Marie-Dominique Blanchin; Michèle Aké; Jérôme Montels; Huguette Fabre
Journal:  Malar J       Date:  2012-05-03       Impact factor: 2.979

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.